These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4238440)

  • 1. [Hypolipemic effect of an association of an extractive mucopolysaccharide and the ethyl ester of the p-chlorophenoxyisobutyric acid].
    Coscelli C; Palmari V; Gnudi A
    Farmaco Prat; 1968 Sep; 23(9):482-90. PubMed ID: 4238440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypocholesterolemic activity of the combination of ethyl-p-chlorophenoxyisobutyrate and extractive sulfomucopolysaccharide].
    Nicrosini F; Butti A; Pasotti C
    Farmaco Prat; 1968 May; 23(5):256-62. PubMed ID: 4238576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical testing of the preparations SPN 40150 and N 150].
    Lietz W
    Z Allgemeinmed; 1973 Aug; 49(24):1135-6. PubMed ID: 4271794
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
    Loizzi P; Terlizzi N
    Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
    [No Abstract]   [Full Text] [Related]  

  • 7. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of the coefficient of peripheral utilization of glucose after venous administration, in hypercholesteremic subjects, after treatment with an antidyslipidemic agent].
    Pasini P
    G Gerontol; 1969 Aug; 17(8):808-16. PubMed ID: 5371744
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 3-glucosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study.
    Ciuffetti G; Mercuri M; Susta A; Lupattelli G; Pasqualini L; Lombardini R; Mannarino E
    Angiology; 1989 Apr; 40(4 Pt 1):255-9. PubMed ID: 2705632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical controlled experimentation of a combination of a peripheral vasodilator agent and a clarifying and hypolipemic agent].
    Nicrosini F; Butti A; Pasotti C
    Farmaco Prat; 1969 Mar; 24(3):157-66. PubMed ID: 4238678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic action of an injectable mucopolysaccharide extract in arteriosclerotic hyperlipemia].
    Nicrosini F
    Farmaco Prat; 1966 Dec; 21(12):677-87. PubMed ID: 4230025
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulodexide in the therapy of vasculopathies].
    Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
    Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
    Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
    Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of the antidyslipemic action of a sulfomucopolysaccharide of pancreatic origin].
    Svetoni N; D'Alonzo D; Rechichi A
    Clin Ter; 1974 Oct; 71(1):33-48. PubMed ID: 4279159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of coronary artery disease.
    Br Med J; 1969 Jan; 1(5635):37-8. PubMed ID: 4973519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.